Iovance Biotherapeutics, Inc. (IOVA)
Iovance Biotherapeutics Market Cap: 936.84M for Jan. 16, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Lantheus Holdings, Inc. | 4.261B |
| Intellia Therapeutics, Inc. | 1.448B |
| Perspective Therapeutics, Inc. | 173.21M |
| Electromed, Inc. | 232.12M |
| InfuSystem Holdings, Inc. | 178.55M |
Market Cap Related Metrics
| PS Ratio | 3.125 |
| Price to Book Value | 1.334 |
| Price | 2.36 |
| Earnings Yield | -50.93% |